The rising landscape of Indian pharmaceuticals is witnessing significant attention on Retatrutide, a novel dual GIP and GLP-1 target exhibiting efficacy for obesity treatment . This peptide is generating considerable anticipation within the healthcare community, particularly as Indian companies i… Read More